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Abstract
Contact-inhibition ubiquitously exists in non-transformed cells and explains the poor regenerative capacity of in vivo human
retinal pigment epithelial cells (RPE) during aging, injury and diseases. RPE injury or degeneration may unlock mitotic block
mediated by contact inhibition but may also promote epithelial-mesenchymal transition (EMT) contributing to retinal
blindness. Herein, we confirmed that EMT ensued in post-confluent ARPE-19 cells when contact inhibition was disrupted
with EGTA followed by addition of EGF and FGF-2 because of activation of canonical Wnt and Smad/ZEB signaling. In
contrast, knockdown of p120-catenin (p120) unlocked such mitotic block by activating p120/Kaiso, but not activating
canonical Wnt and Smad/ZEB signaling, thus avoiding EMT. Nuclear BrdU labeling was correlated with nuclear release of
Kaiso through p120 nuclear translocation, which was associated with activation of RhoA-ROCK signaling, destabilization of
microtubules. Prolonged p120 siRNA knockdown followed by withdrawal further expanded RPE into more compact
monolayers with a normal phenotype and a higher density. This new strategy based on selective activation of p120/Kaiso
but not Wnt/b-catenin signaling obviates the need of using single cells and the risk of EMT, and may be deployed to
engineer surgical grafts containing RPE and other tissues.
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Introduction
Dysfunction and death of retinal pigment epithelium (RPE)
constitute the final common pathway in age-related macular
degeneration, the leading cause of legal blindness among the
elderly (reviewed by Binder et al. [1]), as well as retinitis
pigmentosa [2] and Stargardt’s macular dystrophy [3]. As a
monolayer of cuboidal cells, the RPE monolayer rests on the
Bruch’s membrane and plays a pivotal role in maintaining
photoreceptor functions in vivo (reviewed by Strauss [4]) The
RPE monolayer is also terminally differentiated and mitotically
quiescent in vivo presumably due to contact inhibition [1].
Recently, cell-based therapy has emerged as a promising strategy
for treating diseases characterized by RPE dysfunction [5], leading
to an increasing need of engineering RPE in an ex vivo
environment. Hence, it is also important to develop a new
strategy of switching proliferation in contact-inhibited RPE
without losing its normal phenotype to epithelial-mesenchymal
transition (EMT).
EMT is a common cell biological process prevalent in
embryogenesis but becomes pathogenic in a post-natal life because
it leads to the loss of epithelial cell characteristics and the gain of
mesenchymal phenotype, including expression of a-smooth muscle
actin (a-SMA) (reviewed by Kalluri et al. [6]). Experimentally,
EMT is commonly noted in pre-confluent RPE [7,8] in porcine
RPE explants when cell junctions are disrupted by EGTA followed
by addition of TGF-b2 [9]. EMT also occurs in immediately
confluent ARPE-19 cells in response to epidermal growth factor
(EGF) [10], TGF-b [10–12] or in combination [10] without
knowing whether these confluent ARPE-19 cells have ceased
proliferation due to contact inhibition. EMT is associated with
overexpression of ZONAB or knockdown of ZO-1 that is used to
increase mouse RPE proliferation [13]. Clinically, EMT occurs in
a number of pathological diseases involving RPE (reviewed by
Saika et al. [14]), such as proliferative vitreoretinopathy, in which
RPE undergoes EMT to become fibroblastic and contractile cells,
leading to tractional retinal detachment and blindness (reviewed
by Nagasaki et al. [15] and Pastor et al. [16]). Importantly, the
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attributed to proliferation of abnormal RPE [15]. It remains
unclear whether EMT is inevitable upon loss of contact inhibition
or whether different growth factors might have different impacts
on proliferation, even if EMT is elicited.
Intercellular junctions include gap junctions, adherent junctions
(AJs), and tight junctions, among which AJs play an important role
in controlling many cellular behaviors, including proliferation,
differentiation, and survival (reviewed by Perez-Moreno et al.
[17]). Although not fully elucidated, the mechanism governing
contact inhibition-mediated mitotic block likely involves signaling
transmitted from AJs to the nucleus (reviewed by Jamora et al.
[18], Perez-Moreno et al. [17], and Matter et al. [19]).
Conceivably, two signaling pathways could be elicited via b-
catenin and p120-catenin (hereafter p120), respectively, when AJs
are disrupted. The former is known as the canonical Wnt pathway,
in which b-catenin, if stabilized in the cytoplasm without
ubiquitin-mediated degradation, can be translocated into the
nucleus where it acts as a transcriptional co-activator through
binding with T cell factor/lymphoid enhancer factor (TCF/LEF)
transcription factors (reviewed by Willert et al. [20] and Nelson et
al. [21]). The latter may trigger the p120/Kaiso pathway, in which
nuclear translocated p120 relieves the repressor activity of Kaiso, a
member of BTB/POZ-ZF transcription factor family [22-24] (also
reviewed by Daniel [25]). It has been known that p120 negatively
regulates RhoA and other Rho GTPases [26,27]. However, it is
unclear whether and how activation of RhoA following the release
of p120 inhibition can be linked to p120 nuclear trafficking and
subsequent signaling.
To address the aforementioned issues, we adopted the model of
post-confluent contact-inhibited ARPE-19 cells and noted that
disruption of contact inhibition by EGTA followed by addition of
EGF and FGF-2 indeed triggers EMT by activating canonical
Wnt signaling, which is also sufficient in activating Smad/ZEB1/2
signaling resulting in EMT. Moreover, we discovered a novel
strategy of unlocking such mitotic block by p120 siRNA
knockdown, which selectively activates p120/Kaiso and RhoA-
ROCK, but does not affect Wnt/b-catenin signaling. Conse-
quently, a more compact RPE monolayer ensues and retains a
normal phenotype without EMT after prolonged transfection of
p120 siRNA for 15 days followed by withdrawal. These results
highlight the feasibility of deploying this novel strategy of selective
activation of p120/Kaiso signaling to engineer RPE and other
similar tissues without the use of single cells and to switch
proliferation on in contact-inhibited tissues without risking EMT.
Results
Disruption of contact inhibition by EGTA followed by
EGF+FGF-2 leads to proliferation with EMT
In the model of ARPE-19 cells, our preliminary experiments
showed that BrdU labeling was still detectable 4 days and became
non-detectable 7 days after confluence (Fig. S1). Hence, we chose
to conduct all subsequent experiments at day 7 post-confluence.
We also noted that disruption of cell junctions by EGTA was
critical to unlock contact inhibition as no BrdU labeling was noted
when EGF and/or FGF-2 was added if EGTA was not also added
(not shown). In contrast, with EGTA, additional EGF+FGF-2
caused a significant increase of BrdU labeling index to 21 %.
Nonetheless, such a treatment also altered expression pattern of
several known RPE markers including RPE65, a key enzyme
within the visual cycle and a differentiation marker of RPE cells
located in cytoplasm and at membrane [4] and of ARPE-19 cell
line [28,29], Na,K-ATPase [30], N-cadherin [31,32] and ZO-1
[33]. As compared to their predominant cytolocalization at
intercellular junctions in the control treated with PBS, EGTA
alone did not cause any significant alteration (Fig. 1). However,
EGTA+EGF+FGF-2 abrogated their staining in the intercellular
junctions (Fig. 1). To determine if the loss of RPE phenotype was
coupled with EMT, we studied the expression S100A4 and a-
SMA as a gain of a mesenchymal phenotype (reviewed by Zeisberg
et al. [34] and Schneider et al. [35]). Our result showed that a-
SMA was detected only after EGF+FGF-2 were added (Fig. 1).
These results collectively indicated that contact inhibition
unlocked by EGTA with EGF+FGF-2 was accompanied by loss
of the normal RPE phenotype and gain of a mesenchymal
phenotype suggestive of EMT.
Contact inhibition is uniquely unlocked by down-
regulation of p120 without EMT
Because disruption of cell junctions by EGTA+EGF+FGF-2 ran
the risk of EMT (Fig. 1), we adopted a different approach by
siRNA to perturb components of intercellular junctions including
p120, N-cadherin, a-catenin, b-catenin, or ZO-1. The knockdown
efficiency of these siRNAs was verified by both qRT-PCR and
Western blotting (Fig. S2). For p120, we have tested the efficiency
of 4 different siRNAs, single or in combination, and noted that the
chosen p120 siRNA exhibited the best knockdown efficiency, i.e.,
,95% at the mRNA level and ,80% at protein level.
Furthermore, the efficiency was not improved by various
combinations. Differential Interference Contrast (DIC) microsco-
py showed that the cell morphology was not altered by any siRNA
compared to the scRNA control (Fig. 2A). BrdU nuclear labeling
was only increased in cells transfected with p120 siRNA, which
was partially colocalized with increased nuclear staining of p120
(Fig. 2A, n=6, P,0.05). When compared to the scRNA control,
the membranous and cytoplasmic staining of RPE65, intercellular
junctional staining pattern of N-cadherin, ZO-1, and membranous
staining of Na,K-ATPase remained unchanged in p120 siRNA-
transfected cells (Fig. 2B). Unlike EGTA+EGF+FGF-2 group, cells
transfected with p120 siRNA did not express cytoplasmic S100A4
and a-SMA (Fig. 2B). These results collectively indicated that the
mitotic block could also be unlocked by p120 siRNA knockdown
without perturbing the normal RPE phenotype and without
running the risk of developing EMT.
Wnt and Smad/ZEB signalings are activated by
EGTA+EGF+FGF-2 but not by p120 knockdown
Because S100A4 is a transcriptional target of canonical Wnt
signaling [36], we suspected that the EGTA+EGF+FGF-2
treatment might have activated the Wnt signaling. We thus
transfected post-confluent ARPE-19 cells with a plasmid contain-
ing TCF/LEF promoter construct and simultaneously treated the
cells with XAV939, a specific Wnt inhibitor, which promotes
phosphorylation-dependent degradation of b-catenin by increas-
ing the activity of the destruction complex [37]. The results
showed that the TCF/LEF promoter activity was low in cells
treated with PBS but elevated 15-fold in cells treated with
EGTA+EGF+FGF-2, and such an elevated activity was abolished
by XAV939 (manuscript submitted). In contrast, the activity
remained unchanged in cells transfected with scRNA or p120
siRNA (Fig. 3A, n=3, P,0.05). qPCR disclosed 2.3- to 2.5-fold
elevated levels of b-catenin and LEF1 mRNAs in cells treated with
EGTA+EGF+FGF-2 but not p120 siRNA (Fig. 3B, n=3,
P,0.05). Immunostaining also confirmed that b-catenin was
decreased in the cell junctions but increased in the nuclei, while
there was also a notable increase of LEF1 staining in the nuclei of
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(Fig. 3C). Western blot further confirmed a 2-fold reduced level of
junctional b-catenin but a dramatic increase of nuclear levels of b-
catenin and LEF1 proteins in cells treated with EG-
TA+EGF+FGF-2 but not with p120 siRNA (Fig. 3D). These
results indicated that canonical Wnt signaling was activated by
EGTA+EGF+FGF-2 but not by p120 siRNA.
A number of studies have shown that EMT is induced in a
Smad-dependent manner (reviewed by Xu et al. [38]) via direct
interaction of nuclear p-Smad2/3 with the zinc finger factors
ZEB1 and ZEB2 [39,40]. Immunostaining indeed confirmed that
nuclear staining of p-Smad2/3, ZEB1, and ZEB2 was only noted
in cells treated with EGTA+EGF+FGF-2 but not p120 siRNA
(Fig. 3C). Western blot further confirmed a 2-fold decrease of the
cytoplasmic level but a dramatic increase of the nuclear level of p-
Smad2/3 in cells treated with EGTA+EGF+FGF-2 but not with
p120 siRNA (Fig. 3D). These results suggested that the mitotic
block unlocked by EGTA+EGF+FGF-2, but not p120 siRNA, was
associated with activation of canonical Wnt and Smad/ZEB
signaling.
BrdU labeling is increased by nuclear release of Kaiso
only following nuclear translocation of p120
Although p120 is usually found at cell junctions and undergoes
nucleocytoplasmic shuttling [23,41,42], controversy of nuclear
p120 in normal or tumor cells exists [25]. We suspected that such a
controversy might stem from the difference in the fixative used for
immunostaining. In fact, the nuclear p120 staining was not
apparent when RPE monolayers were treated with 4% parafor-
maldehyde that has been used by others [42–44] but became
apparent when fixed by 25% acetic acid plus 75% methanol
(Fig. S3). To determine whether nuclear p120 triggered by p120
siRNA (Fig. 2A) was responsible for the release of nuclear Kaiso’s
transcriptional repression as suggested [25], we first examined the
expression of p120 and Kaiso transcripts by qPCR. Compared to
the control scRNA group, cells transfected with p120 siRNA
expressed 20- and 6-fold less of p120 and Kaiso transcripts,
respectively (Fig. 4A, n=3, P,0.05). To confirm the above results,
we performed knockdown of 3 other p120 siRNAs with target
sequences: 59GCCAGAGGTGGTTCGGATA39 [43], 59AAC-
GAGGTTATCGCTGAGAAC39 [45], and
59GCGATTGCTTCGAAAGGCTCGTGAT39 (designed by
us), and noted similar results (not shown). As a contrast,
EGTA+EGF+FGF-2 treatment did not alter the level of p120
and Kaiso transcripts. As expected, the BrdU labeling index was
promoted by both EGTA+EGF+FGF-2 and p120 siRNA (Fig. 4B,
n=6,P,0.05). p120 siRNA knockdown markedly reduced p120
staining in the cell junctions but increased that in the nucleus,
where it was partially colocalized with increased nuclear BrdU
staining and with reduced nuclear Kaiso staining. Because Kaiso
transcript was also lowered by p120 siRNA (Fig. 4A), we would
like to rule out whether the use of Kaiso siRNA, which decreased
Kaiso transcript and protein, but to a less extent (Fig. S2A, B),
could have indirectly contributed the aforementioned effect by
p120 siRNA. Our finding showed that Kaiso siRNA alone did not
promote the BrdU labeling and p120 nuclear staining, nor did it
decrease nuclear Kaiso staining. In contrast, simultaneous Kaiso
siRNA and p120 siRNA knockdown synergistically promoted the
BrdU labeling and p120 nuclear staining as well as decreased
Kaiso nuclear staining (Fig. 4B). The aforementioned immuno-
staining differences of p120 and Kaiso were confirmed by
quantitation of both protein levels by Western blotting using
nuclear extracts (Fig. 4C, n=3, P,0.05). We found that there was
a strong inverse correlation between the p120 nuclear level and
the Kaiso nuclear level, suggesting that p120 nuclear translocation
dictated Kaiso nuclear release in promoting BrdU labeling.
To further prove that nuclear translocation of p120 was crucial
for Kaiso nuclear release, we examined the effect of nocodazole
and taxol, which depolymerizes and stabilizes the microtubule
network, respectively, to affect the p120 cytosolic pool, thus
indirectly affecting p120 nuclear translocation [46]. Our result
showed that nocodazole increased the nuclear p120 staining from
3- (samples treated with p120 siRNA) to 6-fold (samples treated
with p120 siRNA+nocodazole), while taxol reduced nuclear p120
to the control level (Fig. 4C). Consequently, the nuclear Kaiso
level was decreased 2-fold by nocodazole but increased to the
control level by taxol. The aforementioned changes in nuclear
p120 and Kaiso levels were also reflected by the extent of nuclear
p120 and Kaiso staining and the BrdU labeling. Collectively, these
results further supported that the mitotic block unlocked by p120
siRNA knockdown was mediated by p120/Kaiso signaling and
that nuclear translocation of p120 played a pivotal role in releasing
the nuclear Kaiso level to unlock the mitotic block in post-
confluent ARPE monolayers.
Figure 1. Contact inhibition disrupted by EGTA followed by EGF+FGF-2 leads to EMT. ARPE-19 cells cultured to day 7 post-confluence
were treated with PBS, 1 mM EGTA, or 1 mM EGTA plus 10 ng/ml EGF and 20 ng/ml FGF-2 for 1 day. Immunostaining to RPE65, N-cadherin, ZO-1,
and Na, K-ATPase was detected in the intercellular junction in PBS and EGTA, but was notably diminished in EGTA+EGF+FGF-2. Positive staining to
S100A4 and a-SMA emerged. Scale bar indicates 100 mm.
doi:10.1371/journal.pone.0036864.g001
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RhoA-ROCK signaling
p120 is known to interact and stabilize microtubules [47] and to
inhibit RhoA and other Rho GTPases [26,27]. Activation of
RhoA signaling can destabilize microtubule [48]. Because
destabilization of microtubules by nocodazole facilitated p120/
Kaiso signaling (Fig. 4), we wondered whether RhoA was activated
by p120 siRNA in a similar manner to nocodazole resulting in
proliferation mediated by p120 nuclear translocation. Indeed we
noted that the level of active RhoA was increased 5-fold by p120
knockdown and 7-fold with additional nocodazole (Fig. 5A). In
contrast, the level of active RhoA promoted by p120 siRNA or
p120 siRNA plus nocodazole was suppressed by Taxol to the
baseline level. Similarly, nuclear p120 staining and BrdU labeling
promoted by p120 siRNA plus nocodazole was abolished by taxol,
CT-04 (a RhoA inhibitor), or Y27632 (a ROCK inhibitor)
(Fig. 5B). These results suggested that activation of RhoA-ROCK
signaling was correlated with destabilization of microtubules, p120
nuclear translocation, and BrdU labeling.
Prolonged p120 knockdown followed by withdrawal
leads to a more compact monolayer with normal ARPE
phenotype without EMT
The above experiments based on a short pulse of 100 nM p120
siRNA knockdown for 48 h was capable of unlocking the ARPE
mitotic block without inducing EMT by selective activation of
p120/Kaiso and RhoA-ROCK signaling (Fig. 2–5). To determine
whether proliferation could be sustained without EMT by
prolonging p120 siRNA transfection, ARPE-19 cells cultured to
day 7 post-confluence were transfected with 40 nM of scRNA,
p120 siRNA, Kaiso siRNA or p120 and Kaiso siRNAs every
5 days for 15 days and then withdrawn for another 15 days. The
starting cell density was 22.361.5610
4/mm
2 (scRNA)
22.061.0610
4/mm
2 (p120 siRNA), 23.061.0610
4/mm
2 (Kaiso
siRNA), and 22.762.1610
4/mm
2 (both siRNAs), respectively, on
Figure 2. Contact inhibition is unlocked without EMT by p120 knockdown. ARPE-19 cells cultured to post-confluence day 7 were
transfected with 100 nM scRNA or siRNAs to such junctional components as p120, N-cadherin, a-catenin, b-catenin, and ZO-1 for 2 days, and cultured
in the presence of 10 mm BrdU for 4 h before fixation in acid/methanol. (A) DIC cell morphology was not altered by any siRNA compared to the scRNA
control. BrdU nuclear labeling was only increased in cells transfected with p120 siRNA, where some were colocalized with nuclear translocation of
p120. (B) Immunostaining of RPE65, N-cadherin, ZO-1, Na,K-ATPase, S100A4, and a-SMA in cells transfected with p120 siRNA was similar to that of the
scRNA control. Scale bar indicates 100 mm and * denotes P,0.05.
doi:10.1371/journal.pone.0036864.g002
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transfection. The ARPE monolayers transfected with scRNA or
Kaiso siRNA virtually remained quiescent during this period in
terms of morphology (not shown) or cell density (Fig. 6A). In
contrast, ARPE monolayers transfected with p120 siRNA or
double siRNAs continued to increase cell density to 1.5- and 1.7-
fold during the entire 15 days of transfection (Fig. 6A, n=3,
P,0.05). After termination of siRNA transfection for another
Figure 3. Activation of Wnt and Smad/ZEB signaling by EGTA+EGF+FGF-1 but not p120 knockdown. ARPE-19 cells cultured to day 7
post-confluence were treated with PBS or 1 mM EGTA plus 10 ng/ml EGF and 20 ng/ml FGF-2 for 1 day with or without 5 ng/ml XAV939, or
transfected with 100 nM scRNA or p120 siRNA for 2 days. (A) The TCF/LEF1 promoter activity was silent in PBS, scRNA, or p120 siRNA, dramatically
elevated to nearly 16-fold by EGTA+EGF+FGF-2 (P,0.05), but completely abolished by XAV939 (not shown). (B) qRT-PCR showed that b-catenin and
LEF1 transcripts were up-regulated 2.2- and 2.5-fold, respectively (P,0.05), in EGTA+EGF+FGF-2, but remained unchanged in p120 siRNA (P.0.05). (C)
Immunostaining reveal increased nuclear staining of b-catenin, LEF1, p-Smad2/3, ZEB1, and ZEB2 in EGTA+EGF+FGF-2 but not p120 siRNA. Scale bar
indicates 100 mm. (D) Western blot analysis confirmed that the b-catenin level decreased in the membranous extract but increased in the nuclear
extract, while the LEF1 level increased in the nuclear extract in EGTA+EGF+FGF-2, while there was no such change by p120 siRNA. Connexin43, a-
tubulin, and histone serve as the loading control for membranous, cytosolic, and nuclear extracts, respectively.
doi:10.1371/journal.pone.0036864.g003
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36864Figure 4. Correlation between BrdU labeling and nuclear translocation of p120 and nuclear release of Kaiso. ARPE-19 cells cultured to
day 7 post-confluence were treated with PBS or 1 mM EGTA with 10 ng/ml EGF plus 20 ng/ml FGF-2 for 1 day, or transfected with 100 nM scRNA or
siRNA to p120, Kaiso, or both for 2 days, and cultured in the presence of 10 mm BrdU for 4 h before fixation with acid/methanol. During p120 siRNA
transfection, some cultures were added with 5 mg/ml nocodazole or 10 ng/ml taxol. (A) qRT-PCR showed that p120 and Kaiso transcripts remained
unchanged by EGTA+EGF+FGF-2 but were 20- and 6-fold suppressed, respectively, by p120 siRNA. (B) As expected, the BrdU labeling index was
significantly increased by EGTA+EGF+FGF-2 and p120 siRNA. Compared to scRNA, the BrdU labeling was not changed by Kaiso siRNA alone, but was
significatly incrased when Kaiso siRNA was added with p120 siRNA. Compared to p120 siRNA, the BrdU labeling was further promoted from 23% to
35% by nocodazole, but decreased to 0.2% by taxol. Such changes of BrdU labeling index was correlated with increasing p120 nuclear staining and
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31.361.6610
4/mm
2 (p120 siRNA) and 35.461.5610
4/mm
2
(both siRNAs), which was significantly higher than
23.361.5610
4/mm
2 (scRNA) and 23.561.4610
4/mm
2 (Kaiso
siRNA) (Fig. 6A, P,0.05 and P,0.01 respectively).
Additionally, immunostaining confirmed that normal RPE
phenotype, judged by membranous and cytoplasmic staining of
RPE65, junctional staining of N-cadherin, a-catenin, b-catenin,
ZO-1, and membranous staining of Na,K-ATPase as well as by
peri-membranous staining of F-actin, was maintained in the
control transfected with scRNA (Fig. 6B). Prolonged p120 siRNA
knockdown for 15 days resulted in significant reduction of p120
junctional staining and increase of p120 nuclear staining, similar to
what was shown in Figure 4. Neither scRNA nor p120 siRNA
resulted in enhanced or positive expression of EMT markers, i.e.
S100A4, and a-SMA (not shown). However, prolonged p120
siRNA knockdown notably reduced peri-junctional staining of F-
actin and mildly reduced membranous and cytoplasmic staining of
RPE65, junctional staining of N-cadherin, a-catenin, b-catenin,
ZO-1, and membranous staining of Na-K-ATPase (Fig. 6B).
Fifteen days after withdrawal of p120 siRNA, the immunostaining
pattern was completely reverted to that of the control for all these
6 markers (Fig. 6B). Taken together, these results indicated that
prolonged p120 siRNA knockdown further promoted the prolif-
erative potential and cell density of post-confluent ARPE
monolayer without EMT. Following withdrawal of p120 siRNA,
the normal ARPE phenotype was completely restored in 15 days.
Discussion
To unlock the mitotic block of contact-inhibited ARPE-19 cells
to induce EMT, it was necessary to disrupt the cell junctions with
EGTA, a notion that has been reported in TGF-b2-added porcine
RPE explants [9] and in other TGF-b1-added confluent epithelial
cells [49,50]. Nonetheless, in our model system, we noted that
addition of EGF and FGF-2 without TGF-b was also sufficient and
necessary to induce EMT (Fig. 1). Unlike TGF-b, which induces
EMT while inhibiting proliferation, EGF+FGF-2 induced EMT
while promoting proliferation. This unique action by EG-
TA+EGF+FGF-2 could be explained by selective activation of
canonical Wnt signaling because both EMT and proliferation
were completely abolished by XAV399 (manuscript submitted), a
specific Wnt inhibitor [37]. Interestingly, addition of EGF +FGF-2
without TGF-b was also sufficient to elicit nuclear translocation of
decreasing Kaiso nuclear staining. (C) The above changes were supported by Western blot which showed an inverse relationship between the p120
level and the Kaiso level in nuclear extracts using histone as the loading control. Scale bar indicates 100 mm, while *, {, and { denote P,0.05.
doi:10.1371/journal.pone.0036864.g004
Figure 5. RhoA-ROCK signaling controls nuclear p120 translocation and BrdU labeling. (A) The level of active RhoA was promoted 5-fold
by p120 siRNA and 7-fold with addition of nocodazole. The level of active RhoA promoted by p120 siRNA or p120 siRNA+nocodazole was inhibited by
taxol to the baseline. (B) Nuclear BrdU labeling and p120 staining promoted by p120 siRNA+nocodazole was abolished by Taxol, CT-04 (RhoA
inhibitor), or Y27632 (ROCK inhibitor). Scale bar indicates 100 mm.
doi:10.1371/journal.pone.0036864.g005
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activated by EGTA+EGF+FGF-2 was sufficient to activate Smad/
ZEB signaling, which is known to cause EMT in many other
epithelial cells (reviewed by Polette et al. [51]). The role of
canonical Wnt signaling in contributing to the Smad signaling has
also been noted in other systems (reviewed by Massague et al.
[52]), including kidney [53] and intervetebral disc [54]. Taken
together, we conclude that the conventional method of expanding
contact-inhibited post-confluent ARPE-19 cells based on EG-
TA+EGF+FGF-2 runs the risk of developing EMT.
For the first time, we discovered a novel method of unlocking
such mitotic block without frank disruption of cell junctions
through the use of p120 siRNA (Fig. 2). As a contrast to
EGTA+EGF+FGF-2, p120 siRNA knockdown did not cause
EMT in part because of the lack of activation of canonical Wnt
and Smad/ZEB signaling (Fig. 3). Our study further showed that
this unique method based on p120 siRNA was mediated by
selective activation of the p120/Kaiso signaling (Fig. 4). p120 is
known to regulate cadherin-mediated adherent junctions, to
stabilize them at the membrane by regulating the dynamic
regulation of the actin cytoskeleton [27], to transport cadherins to
the membrane, to stabilize cadherins at the membrane [17], and
most importantly, to stimulate proliferation by regulating the
activity of Rho GTPases including RhoA (reviewed by Rossman
et al. [55]). We noted that thrombin (5U/ml, 5 min), H2O2
(200 mM, 30 min), LPA (1 mg/mL, 30 min), and HGF (10 ng/
mL, 24 h), known activators of RhoA/ROCK signaling, resulted
in increased proliferation in subconfluent but not post-confluent
contact-inhibited ARPE-19 cells (not shown). Because p120 acts as
a guanine nucleotide dissociation inhibitor by binding to and
preventing RhoA activity [26,54], we thus believe that knockdown
of p120 is a unique mechanism to activate RhoA/ROCK in
contact-inhibited RPE cells by releasing such an inhibition of
RhoA activity but not by direct activation of RhoA/ROCK. A
same result was noted in primary post-confluent hutman corneal
endothelial cells [56]. Unlike our finding, others reported that
Figure 6. Compact ARPE monolayer with a normal phenotype without EMT after prolonged p120 knockdown. ARPE-19 cells cultured
to day 7 post-confluence were transfected with 40 nM scRNA or siRNA to p120, Kaiso, or both for every 5 days until day 15, followed by withdraw for
another 15 days. (A) The baseline cell density was comparable before (day 0) transfection, and reached a plateau of 24.762.5610
4/mm
2 (n=3) and
24.062.7610
4/mm
2 (n=3, P.0.05) in scRNA and Kaiso siRNA, respectively. In contrast, it increased to 33.761.5610
4/mm
2 (n=3, P,0.05) and
38.362.1610
4/mm
2 (n=3, P,0.01), respectively, in p120 siRNA or both siRNAs on day 15. After withdrawal, the final density of all groups slightly
decreased on day 30, when same cell morphology was noted as day 15 but dome-shaped areas disappeared (* P,0.05). (B) Immunostaining revealed
decreased peri-membranous staining of F-actin and mildly decreased junctional staining of p120, N-cadherin, a-catenin, b-catenin, ZO-1,
membranous and junctional staining of RPE65, membranous staining of Na,K-ATPase after p120 siRNA transfection for 15 days. Normal expression
patterns were regained after withdrawal for 15 days. Scale bar indicates 100 mm.
doi:10.1371/journal.pone.0036864.g006
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E-cadherin in tumor epithelial cells [43,57], VE-cadherin in
vascular endothelial cells [43,58,59], N-cadherin in cardiac
myocytes [43,60], and vascular endothelial cells [59] without
demonstrating the effect of promoting proliferation. We attributed
such a disparity to their use of EDTA/trypsin dissociated but not
post-confluent contact-inhibited cells because we also noted that
p120 knockdown actually reduced cell proliferation when ARPE-
19 cells are divided into single cells by EDTA/trypsin (unpub-
lished observation). These data highlight a unique role of p120 in
governing contact inhibition in post-confluent cultures.
The finding that p120 siRNA knockdown activates p120/Kaiso
signaling was supported by a dramatic shift of its cytolocalization
from the junction/membrane to the nucleus, where it was
correlated with the release of nuclear Kaiso (Fig. 4B). This unique
mode of action clearly involves nucleocytoplasmic shuttling of
p120, which can be modulated by extrinsic factors such as
cadherin binding [41,42] and interactions with the microtubule
network [42,45]. Consistent with what has been shown in a
number of cell lines [42], the extent of nuclear p120 level elicited
by p120 knockdown could further be augmented by nocodazole, a
microtube-disrupting agent, but diminished by taxol, a microtube-
stabilizing agent (Fig. 4), implying that indeed p120 shuttling from
the cytoplasm to the nucleus could further be facilitated by
perturbing the microtubular network. It is worth noting that p120
nuclear translocation could not be elicited by Kaiso siRNA
knockdown alone (Fig. 4B, C), which like p120 siRNA also
downregulated Kaiso mRNA and protein, a finding that was also
noted in porcine pulmonary artery endothelial cells [24]. The
finding that Kaiso siRNA alone could not alter the nuclear level of
Kaiso suggested that the homeostasis of nuclear Kaiso is tightly
regulated and cannot be influenced by its own transcription and
translation in a short term. In contrast, Kaiso siRNA could do so
only in conjunction with p120 siRNA (Fig. 4B, C), resembling
what has been shown in H. pylori mediated up-regulation of MMP-
7 in MKN28 cells [61]. The finding that the nuclear level of Kaiso
could only be reduced by p120 nuclear translocation also
highlighted the specificity of p120/Kaiso signaling, and was
supported by the finding that the binding domain of Kaiso with
p120 is in the same domain where it binds with DNA [23].
Consequently, we observed a consistent inverse relationship
between the nuclear p120 level and the nuclear Kaiso level, of
which the latter was strongly correlated with nuclear BrdU
labeling. These results suggest that unleashing the suppressive
effect by Kaiso plays a key role in unlocking the mitotic block
mediated by contact inhibition in post-confluent ARPE-19 cells.
The notion that the p120/Kaiso signaling activated by p120
siRNA was facilitated by destabilization of microtubules is
supported by the finding that p120 is capable of regulating
microtubule dynamics in a cadherin-independent manner [62].
Consistent with the known action of p120 in downregulating
RhoA [26,27], p120 knockdown activated RhoA-ROCK signaling
(Fig. 5), which was associated with destabilization of microtubules.
We discovered that p120 nuclear translocation induced by p120
knockdown was dependent on activation of RhoA-ROCK
signaling and destabilization of microtubules because inhibition
of RhoA by CT-4 or ROCK by Y-27632 or stabilization of
microtubules by Taxol abolished p120 nuclear translocation and
BrdU labeling (Fig. 5).
It has been reported that stable and continuous knockdown of
p120 induces anchorage-independent growth in NIH3T3 cells
[44]. Herein, we demonstrated that transient, or even prolonged
(up to 15 days) exposure to p120 siRNA, followed by withdrawal
could switch on and off cellular proliferation in contract-inhibited
ARPE-19 cells while maintaining the expression pattern of several
markers (Fig. 6). Further studies are needed to confirm that such a
phenotype is consistent with their in vivo function, e.g., phagocy-
tosis of photoreceptor outer segments or processing of visual cycle
molecules. Furthermore, if p120 siRNA might be safely delivered
in vivo, one may consider using it to treat diseases characterized by
RPE dysfunction or degeneration due to aging and injury, where
proliferation is absent or when stimulated might lead to EMT.
Before such applications can be realized, the discovery made in
this study should allow us to engineer functional RPE tissue ex vivo
without the use of enzymatically-dissociated single cells for RPE
transplantation with or without gene targeting.
Materials and Methods
Ethics Statement
No human participants were involved or animal work was
conducted in this study.
Antibodies and Reagents
Dulbecco’s modified Eagle’s medium (DMEM), Ham’s/F12
medium, human epidermal growth factor (EGF), HEPES buffer,
phosphate-buffered saline (PBS), amphotericin B, gentamicin, fetal
bovine serum (FBS), and Alexa fluor-conjugated secondary
antibodies IgG were purchased from Invitrogen (Carlsbad, CA).
FGF-2, TGF-b1, bovine serum albumin, agarose, PCR marker,
paraformaldehyde, methanol, Triton X-100, XAV939, and
Hoechst 33342 dye, nocodazole, and taxol were purchased from
Sigma (St. Louis, MO) or Calbiochem (La Jolla, CA). Specific
monoclonal antibodies (against a-tubulin, a-SMA, b-catenin,
BrdU, Kaiso, N-cadherin, Na,K-ATPase, p-Smad2/3, RPE65,
and RhoA) and polyclonal antibodies (against a-catenin, con-
nexin-43, histone, p120-catenin, S100A4, ZEB1, ZEB2, and ZO-
1) were purchased from Abcam (La Jolla, CA), BD Biosciences
(San Jose, CA), Cell Signaling Technology (Danvers, MA),
Chemicon (Temecula, CA), Upstate (Billerica, MA), Cytoskeleton
(Denvor, CO), Santa Cruz Biotechnology (Santa Cruz, CA),
Sigma, and Zymed (Carlsbad, CA) (For more details see
Table S1). RNeasy Mini Kit was purchased from Qiagen
(Valencia, CA). High Capacity Reverse Transcription Kit and
TaqMan Universal PCR Mater Mix were obtained from Applied
Biosystems (Foster City, CA). Control scramble RNA (scRNA) and
HP validated siRNAs to N-cadherin, a-catenin, b-catenin, ZO-1,
and Kaiso were purchased from Qiagen (Catalog Number
SI02663927, S102654673, SI02662478, SI02655149, and
S104165924 respectively). HiPerfect
H siRNA and SuperFect
H
plasmid transfection reagents were obtained from Qiagen. p120
siRNA3 was designed by ourselves and obtained from Invitrogen
with the target sequence of 59CAGAGGTGATCGC-
CATGCTTGGATT39. The TCF/LEF reporter plasmid kit was
from SABiosciences (Valencia, CA).
Culture, Treatments, and Transfection
All experiments were performed using ARPE-19 (ATCC,
Manassas, Virginia), passages 1–6, cultured in HEPES-buffered
DMEM and Ham’s F-12 (1:1) supplemented with 10% FBS,
2 mM L-glutamine, 50 mg/ml gentamicin, and 1.25 mg/ml
amphotericin B at 37uC in humidified air with 5% CO2. Medium
was changed every 2–3 days. Upon 100% confluence, cells were
continuously cultured for 7 days before being treated with 1 mM
EGTA, 10 ng/ml EGF, 20 ng/ml FGF-2, or XAV939 (a specific
tankyrase I inhibitor antagonist of Wnt signaling [37]) for 1 day or
transfected with siRNAs (described below) for 2 days. Serial
experiments were performed to confirm that the transfection
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short-pulse siRNA knockdown, transfection was performed by
mixing HiPerfect
H siRNA transfection reagents (final dilution,
1:300) and serum- and antibiotic-free medium to a polystyrene
tube followed by incubation for 15 min at room temperature.
Scrambled RNA (scRNA), or siRNA (final concentration,
100 nM) to p120, N-cadherin, a-catenin, b-catenin, ZO-1, or
Kaiso was added to the above mixture, mixed gently by pipetting,
and incubated for another 15 min. The transfection mixture was
added dropwise to a well of a 24-well dish with ARPE cultured in
250 ml of fresh serum-containing medium. Some cultures were
treated with 5 ng/ml nocodazole or 10 mM taxol in the medium
during the entire period of p120 siRNA transfection. For
prolonged p120 siRNA knockdown, post-confluent ARPE cells
on day 7 were transfected with 40 nM scRNA or p120 siRNA
added in the same manner as above every 5 days for 15 days
before switch to siRNA-free fresh medium for another 15 days.
The proliferative status was assessed by addition of BrdU to a final
concentration of 10 mM in the culture medium for 4 h before
termination. The resultant cell density per mm
2 was determined
by counting cells at 3 random fields taken by DIC microscopy at a
high magnification.
Immunofluorescence Confocal Microscopy
ARPE monolayer cultures were air-dried and fixed in 4%
paraformaldehyde, pH 7.0, for 15 min at room temperature,
rehydrated in PBS, incubated with 0.2% Triton X-100 for 15 min,
and rinsed three times with PBS for 5 min each. After incubation
with 2% BSA to block nonspecific staining for 30 min, they were
incubated with appropriate primary antibodies, of which dilutions
are provided in Table S1, for 16 h at 4uC. After three washes with
PBS, they were incubated with corresponding Alexa Fluor-
conjugated secondary IgG for 60 min. For BrdU staining and
nuclear localization staining of p120, samples were fixed with 75%
methanol plus 25% acetic acid for 15 min, denatured by 2 M HCl
for 30 min at 37uC and neutralized by 0.1 M borate buffer, pH
8.5 for 5 min three times. Secondary antibodies IgG (donkey anti-
mouse, donkey anti-rabbit, and donkey anti-goat), conjugated to
Alexa 488, 555, or 633 respectively, were used at 1.7 mg/ml. The
samples were then counterstained with Hoechst 33342 and
analyzed with Zeiss LSM 700 confocal microscope (Thornhood,
NY). Corresponding mouse and rabbit sera were used as negative
controls for primary monoclonal and polyclonal antibodies,
respectively.
Preparation of Cell Lysates
To prepare protein extracts from the membrane, the cytosol,
and the nucleus, we followed Qproteome Cell Compartment
protocol (Qiagen). Briefly, cells were first added with Extraction
Buffer CE1, which selectively disrupts, but without solubilizing,
the plasma membrane, resulting in isolation of cytosolic proteins,
followed by centrifugation at 1006g for 10 min to pellet plasma
membranes and compartmentalized organelles, such as nuclei,
mitochondria, and the endoplasmic reticulum. The pellet was then
resuspended in Extraction Buffer CE2, which solubilizes the
plasma membrane as well as all organelle membranes except the
nuclear membrane, followed by centrifugation at 60006g for
10 min to pellet nuclei. The supernatant contains membrane
proteins and proteins from the endoplasmic reticulum and
mitochondria. Finally, the pellet containing nuclei was solubilized
using Extraction Buffer CE3, in which all soluble and most
membrane-bound nuclear proteins are extracted, and then
pelleted by centrifugation at 68006g for 10 min.
RhoA Activity Assay
The assay of Rho activation was performed in 100 mg of protein
of cell lysates using RhoA Activation Assay Biochem Kit
(Cytoskeleton) to pull down the GTP-bound form of RhoA by a
GST fusion protein containing rhotekin (7–89 residues) and RBD
protein using brightly colored glutathione affinity beads. The
amount of activated RhoA pulled down was quantitatively
determined by Western blot using anti-RhoA antibody.
Western Blotting
The protein extracts from the above three compartments were
electrophoresized on 4–15% (w/v) gradient acrylamide ready gels
(Bio-Rad, Hercules, CA) under denaturing and reducing condi-
tions, and transferred to a nitrocellulose membrane (Bio-Rad),
which was then blocked with 5% (w/v) fat-free milk powder in
Tris-buffered saline [10 mM TrisNHCl (pH 7.4) and 150 mM
NaCl (TBS)] +0.05% Tween 20 (TBST) for 1 hour, washed three
times for 10 min with TBST. After incubation with specific
primary antibodies against b-catenin, LEF1, p-Smad2/3, ZEB1,
and ZEB2, washed three times for 10 min with TBST, the
membranes were incubated for 1 hour with horseradish peroxi-
dase-conjugated secondary antibodies diluted in TBST using
Cx43, a-tubulin, and histone as loading controls for the
membranous, cytosolic, and nuclear compartments, respectively.
Then membranes were washed twice for 10 min with TBST and
once for 5 min with TBS, and then immunoreactive proteins were
detected with Western Lighting
TM Chemiluminesence Reagent
(PerkinElmer, Waltham, MA). Densitometry analysis was per-
formed with computer software (ImageJ; National Institutes of
Health, Bethesda, MD).
RNA Extraction, Reverse Trascription, and Real-Time PCR
Total RNAs were extracted using RNeasy Mini Kit and reverse-
transcribed using High Capacity Reverse Transcription Kit.
cDNA of each cell junction component was amplified by real-
time PCR (qPCR) using specific primer-probe mixtures and DNA
polymerase in 7000 Real-time PCR System (Applied Biosystems,
Foster City, CA). qPCR profile consisted of 10 min of initial
activation at 95uC followed by 40 cycles of 15 sec denaturation at
95uC, and 1 min annealing and extension at 60uC. The genuine
identity of each PCR product was confirmed by the size
determination using 2% agarose gels followed by ethidium
bromide staining together with PCR marker according to EC3
Imaging System (BioImaging System, Upland, CA).
TCF/LEF Promoter Assay
Post-confluent ARPE monolayers in 24-well dishes were
cotransfected with 0.4% (w/v) of the TCF/LEF construct that
harbors TCF/LEF-binding sites and 0.01% (w/v) of pRL-TK
internal control plasmids with 1% (w/v) SuperFect
H plasmid
transfection reagent in the aforementioned medium. After
transfection for 24 h, before adding various treatments in the
fresh medium, cell lysates were assayed for firefly luciferase and
Renilla luciferase activities using a Dual-Luciferase Reporter Assay
System (Promega, Madison, WI) and TD-20/20 luminometer
(Turner BioSystems, Sunnyvale, CA). The ratio of firefly luciferase
and Renilla luciferase activities was used to determine whether the
promoters are activated.
Statistics
All data are presented as blots or images from at least three
similar experiments or as mean 6 S.D. for the number of
experiments (n) indicated. Statistical significance was determined
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software version 13.0 (SPSS Inc. Chicago, Illinois), where P,0.05
was considered statistically significant.
Supporting Information
Figure S1 Proliferation assessed by BrdU labeling was
still positive on day 4 post-confluence, but became
abruptly negative from day 7 post-confluence (* P,0.05).
(TIF)
Figure S2 Knockdown efficiency of siRNA to junctional
proteins and Kaiso. ARPE-19 cells cultured to post-confluence
day 7 were transfected with 100 nM of scRNA or siRNA to
respective junctional components (p120, N-cadherin, a-catenin, b-
catenin, and ZO-1) and Kaiso for 2 days, and processed for total
RNA and cell lysates. (A) qRT-PCR analysis showed that all
siRNAs significantly down-regulated respective mRNA levels
(n=3, * P,0.05). (B) Western blot analysis confirmed that all
proteins were also significantly down-regulated using b-actin as the
loading control (n=3, * P,0.05).
(TIF)
Figure S3 Nuclear p120 staining by different fixatives.
ARPE-19 cells cultured to 25% confluence or day 7 post-
confluence were subjected to fixation in either methanol/acetic
acid (3:1 in v/v) or 4% paraformaldehyde (w/v). Nuclear p120
staining was clearly detected in cells fixed in methanol/acetic acid
but not in paraformadehyde. Scale bar indicates 100 mm.
(TIF)
Table S1 Primary antibodies used for immunfluores-
cence confocal microscopy and Western blotting.
(DOC)
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